Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat in Acute ST Elevation Myocardial Infarction
NCT04803864Phase 2Unknown
- Sponsor
- Ruijin Hospital
- Start
- Jun 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roxadustat in ST elevation myocardial infarction (STEMI), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
roxadustat
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04803864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04803864.